FidoCure to Transform the Precision Medicine Landscape with New Patent, Accelerating Drug Development for Dogs with Cancer The U.S. Patent and Trademark Office has granted FidoCure an industry-first patent for a novel targeted therapy and biomarker for canine cancer. The patent, assigned U.S.